Abstract
Two cases of successful cadaveric renal transplantation in patients with the Wiskott-Aldrich syndrome have previously been reported in the literature [1,2]. The first patient [1] had an almost uneventful outcome, while the second one [2] had to be treated with highdose methylprednisolone for biopsy-proven cellular rejection. The optimal immunosuppressive regimen in patients with Wiskott-Aldrich syndrome remains unknown. We report here the case of a Wiskott-Aldrich patient who underwent living-related renal transplantation. This patient however developed a number of infectious and non-infectious complications which led to his death 3 months after transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
